[go: up one dir, main page]

IL91941A - Preparation of 6-Anoic and 7-Metanoic Fatty Acids and Their Substances and Intermediate Compounds and Acid 7-] 3-) 4-Fluorophenyl (-1-) 1- Methylethyl (a) - Google Patents

Preparation of 6-Anoic and 7-Metanoic Fatty Acids and Their Substances and Intermediate Compounds and Acid 7-] 3-) 4-Fluorophenyl (-1-) 1- Methylethyl (a)

Info

Publication number
IL91941A
IL91941A IL9194189A IL9194189A IL91941A IL 91941 A IL91941 A IL 91941A IL 9194189 A IL9194189 A IL 9194189A IL 9194189 A IL9194189 A IL 9194189A IL 91941 A IL91941 A IL 91941A
Authority
IL
Israel
Prior art keywords
formula
compound
butyl
ester
chloro
Prior art date
Application number
IL9194189A
Other languages
English (en)
Hebrew (he)
Other versions
IL91941A0 (en
Original Assignee
Sandoz Ag
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=26945992&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=IL91941(A) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by Sandoz Ag filed Critical Sandoz Ag
Publication of IL91941A0 publication Critical patent/IL91941A0/xx
Publication of IL91941A publication Critical patent/IL91941A/en

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D233/00—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings
    • C07D233/54—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings having two double bonds between ring members or between ring members and non-ring members
    • C07D233/64—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings having two double bonds between ring members or between ring members and non-ring members with substituted hydrocarbon radicals attached to ring carbon atoms, e.g. histidine
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/06—Antihyperlipidemics
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C223/00—Compounds containing amino and —CHO groups bound to the same carbon skeleton
    • C07C223/02—Compounds containing amino and —CHO groups bound to the same carbon skeleton having amino groups bound to acyclic carbon atoms of the carbon skeleton
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C51/00—Preparation of carboxylic acids or their salts, halides or anhydrides
    • C07C51/347—Preparation of carboxylic acids or their salts, halides or anhydrides by reactions not involving formation of carboxyl groups
    • C07C51/367—Preparation of carboxylic acids or their salts, halides or anhydrides by reactions not involving formation of carboxyl groups by introduction of functional groups containing oxygen only in singly bound form
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C59/00—Compounds having carboxyl groups bound to acyclic carbon atoms and containing any of the groups OH, O—metal, —CHO, keto, ether, groups, groups, or groups
    • C07C59/40—Unsaturated compounds
    • C07C59/42—Unsaturated compounds containing hydroxy or O-metal groups
    • C07C59/48—Unsaturated compounds containing hydroxy or O-metal groups containing six-membered aromatic rings
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D209/00—Heterocyclic compounds containing five-membered rings, condensed with other rings, with one nitrogen atom as the only ring hetero atom
    • C07D209/02—Heterocyclic compounds containing five-membered rings, condensed with other rings, with one nitrogen atom as the only ring hetero atom condensed with one carbocyclic ring
    • C07D209/04—Indoles; Hydrogenated indoles
    • C07D209/10—Indoles; Hydrogenated indoles with substituted hydrocarbon radicals attached to carbon atoms of the hetero ring
    • C07D209/12—Radicals substituted by oxygen atoms
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D209/00—Heterocyclic compounds containing five-membered rings, condensed with other rings, with one nitrogen atom as the only ring hetero atom
    • C07D209/02—Heterocyclic compounds containing five-membered rings, condensed with other rings, with one nitrogen atom as the only ring hetero atom condensed with one carbocyclic ring
    • C07D209/04—Indoles; Hydrogenated indoles
    • C07D209/10—Indoles; Hydrogenated indoles with substituted hydrocarbon radicals attached to carbon atoms of the hetero ring
    • C07D209/18—Radicals substituted by carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals
    • C07D209/24—Radicals substituted by carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals with an alkyl or cycloalkyl radical attached to the ring nitrogen atom

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Engineering & Computer Science (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Public Health (AREA)
  • Obesity (AREA)
  • Diabetes (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Hematology (AREA)
  • Veterinary Medicine (AREA)
  • Oil, Petroleum & Natural Gas (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Indole Compounds (AREA)
  • Pyrane Compounds (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Heterocyclic Carbon Compounds Containing A Hetero Ring Having Oxygen Or Sulfur (AREA)
  • Steroid Compounds (AREA)
IL9194189A 1988-10-13 1989-10-11 Preparation of 6-Anoic and 7-Metanoic Fatty Acids and Their Substances and Intermediate Compounds and Acid 7-] 3-) 4-Fluorophenyl (-1-) 1- Methylethyl (a) IL91941A (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US25747588A 1988-10-13 1988-10-13
US35553189A 1989-05-22 1989-05-22

Publications (2)

Publication Number Publication Date
IL91941A0 IL91941A0 (en) 1990-06-10
IL91941A true IL91941A (en) 1994-10-21

Family

ID=26945992

Family Applications (1)

Application Number Title Priority Date Filing Date
IL9194189A IL91941A (en) 1988-10-13 1989-10-11 Preparation of 6-Anoic and 7-Metanoic Fatty Acids and Their Substances and Intermediate Compounds and Acid 7-] 3-) 4-Fluorophenyl (-1-) 1- Methylethyl (a)

Country Status (24)

Country Link
EP (2) EP0363934B1 (bg)
JP (1) JP2853227B2 (bg)
KR (1) KR0162656B1 (bg)
AT (1) ATE99281T1 (bg)
AU (1) AU636122B2 (bg)
BG (1) BG60555B1 (bg)
CA (1) CA2000553C (bg)
CZ (1) CZ283316B6 (bg)
DE (1) DE68911834T2 (bg)
DK (1) DK175073B1 (bg)
ES (1) ES2060712T3 (bg)
FI (1) FI98063C (bg)
HK (1) HK49496A (bg)
HU (1) HU207993B (bg)
IE (2) IE940109L (bg)
IL (1) IL91941A (bg)
MY (1) MY105067A (bg)
NO (1) NO174623C (bg)
NZ (1) NZ230973A (bg)
RO (1) RO109732B1 (bg)
SG (1) SG139553A1 (bg)
SK (1) SK579789A3 (bg)
WO (1) WO1990003962A1 (bg)
YU (1) YU48466B (bg)

Families Citing this family (24)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5118853A (en) * 1988-10-13 1992-06-02 Sandoz Ltd. Processes for the synthesis of 3-disubstituted aminoacroleins
US5290946A (en) * 1988-10-13 1994-03-01 Sandoz Ltd. Processes for the synthesis of 3-(substituted indolyl-2-yl)propenaldehydes
CA2027179A1 (en) * 1989-10-10 1991-04-11 Barry C. Ross Chemical compounds
DE4424525A1 (de) * 1994-07-12 1995-01-26 Elmar Meyer Dauermagnet-Kolbenmotor
GT199800127A (es) 1997-08-29 2000-02-01 Combinaciones terapeuticas.
IL148127A0 (en) 1999-08-30 2002-09-12 Aventis Pharma Gmbh Use of inhibitors of the renin-angiotensin system in the prevention of cardiovascular events
JP2003535077A (ja) 2000-05-26 2003-11-25 チバ スペシャルティ ケミカルズ ホールディング インコーポレーテッド インドール誘導体を製造する方法、および該方法の中間体
US7777006B2 (en) 2002-12-31 2010-08-17 Csl Behring L.L.C. Method for purification of alpha-1-antitrypsin
WO2004094377A1 (ja) * 2003-04-24 2004-11-04 Daicel Chemical Industries Ltd. 光学活性なジヒドロキシヘプテン酸エステルの分離方法
ATE417827T1 (de) 2003-06-18 2009-01-15 Teva Pharma Fluvastatin-natrium in der kristallform xiv, verfahren zu deren herstellung, diese enthaltende zusammensetzungen und enstprechende anwendungsverfahren
US7368581B2 (en) 2003-06-18 2008-05-06 Teva Pharmaceutical Industries Ltd. Process for the preparation of fluvastatin sodium crystal from XIV
US7368468B2 (en) 2003-06-18 2008-05-06 Teva Pharmaceutical Industries Ltd. Fluvastatin sodium crystal forms XIV, LXXIII, LXXIX, LXXX and LXXXVII, processes for preparing them, compositions containing them and methods of using them
US8415364B2 (en) 2003-11-26 2013-04-09 Duke University Method of preventing or treating glaucoma
US7851624B2 (en) 2003-12-24 2010-12-14 Teva Pharamaceutical Industries Ltd. Triol form of rosuvastatin and synthesis of rosuvastatin
US20060211752A1 (en) 2004-03-16 2006-09-21 Kohn Leonard D Use of phenylmethimazoles, methimazole derivatives, and tautomeric cyclic thiones for the treatment of autoimmune/inflammatory diseases associated with toll-like receptor overexpression
US7741317B2 (en) 2005-10-21 2010-06-22 Bristol-Myers Squibb Company LXR modulators
US7888376B2 (en) 2005-11-23 2011-02-15 Bristol-Myers Squibb Company Heterocyclic CETP inhibitors
EP1847529B1 (en) 2006-04-20 2009-05-20 F.I.S. Fabbrica Italiana Sintetici S.P.A. Process for the preparation of Fluvastatin Sodium salt
EP2327682A1 (en) 2009-10-29 2011-06-01 KRKA, D.D., Novo Mesto Use of amphiphilic compounds for controlled crystallization of statins and statin intermediates
WO2010069593A1 (en) 2008-12-19 2010-06-24 Krka, D. D., Novo Mesto Use of amphiphilic compounds for controlled crystallization of statins and statin intermediates
AU2013214693B2 (en) 2012-02-02 2017-02-23 Kenneth Gek-Jin OOI Improvements in tear film stability
RU2618628C1 (ru) 2013-04-17 2017-05-05 Пфайзер Инк. Производные N-пиперидин-3-илбензамида для лечения сердечно-сосудистых заболеваний
WO2016055901A1 (en) 2014-10-08 2016-04-14 Pfizer Inc. Substituted amide compounds
CA3125765A1 (en) 2019-01-18 2020-07-23 Astrazeneca Ab Pcsk9 inhibitors and methods of use thereof

Family Cites Families (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB945536A (en) * 1961-09-08 1964-01-02 Istituto Chemioterapico Method of preparing ª -amino-acroleins
US4739073A (en) * 1983-11-04 1988-04-19 Sandoz Pharmaceuticals Corp. Intermediates in the synthesis of indole analogs of mevalonolactone and derivatives thereof
HU204253B (en) * 1982-11-22 1991-12-30 Sandoz Ag Process for producing mevalonolactone analogues and derivatives and pharmaceutical compositions containing them
US4571428A (en) * 1983-07-08 1986-02-18 Sandoz, Inc. 6-Substituted-4-hydroxy-tetrahydropyran-2-ones
US4650890A (en) * 1984-04-03 1987-03-17 Sandoz Corp. Preparation of olefinic compounds and intermediates thereof
DE3582674D1 (de) * 1984-06-22 1991-05-29 Sandoz Ag Pyrazolanaloge von mevalonolakton und abkoemmlinge davon, verfahren zu deren herstellung und deren verwendung.
ATE60571T1 (de) * 1984-12-04 1991-02-15 Sandoz Ag Inden-analoga von mevalonolakton und ihre derivate.
US4668794A (en) * 1985-05-22 1987-05-26 Sandoz Pharm. Corp. Intermediate imidazole acrolein analogs
JPS6322056A (ja) * 1986-04-30 1988-01-29 サンド・アクチエンゲゼルシヤフト オレフイン性化合物の製造法
PT85662B (pt) * 1986-09-10 1990-06-29 Sandoz Sa Processo para a preparacao de derivados de aza-indol e de indolizina e de composicoes farmaceuticas que os contem

Also Published As

Publication number Publication date
ES2060712T3 (es) 1994-12-01
IE63477B1 (en) 1995-04-19
YU197389A (en) 1990-12-31
AU4344889A (en) 1990-05-01
DK144690D0 (da) 1990-06-13
ATE99281T1 (de) 1994-01-15
KR900701723A (ko) 1990-12-04
FI902935A0 (fi) 1990-06-12
BG92179A (bg) 1993-12-24
HK49496A (en) 1996-03-29
WO1990003962A1 (en) 1990-04-19
AU636122B2 (en) 1993-04-22
DK144690A (da) 1990-06-13
KR0162656B1 (ko) 1999-01-15
SG139553A1 (en) 2008-02-29
IL91941A0 (en) 1990-06-10
JPH03501735A (ja) 1991-04-18
DK175073B1 (da) 2004-05-24
DE68911834T2 (de) 1994-06-23
CZ283316B6 (cs) 1998-02-18
NO174623C (no) 1994-06-08
NO174623B (no) 1994-02-28
RO109732B1 (ro) 1995-05-30
JP2853227B2 (ja) 1999-02-03
NZ230973A (en) 1993-03-26
BG60555B1 (en) 1995-08-28
SK280845B6 (sk) 2000-08-14
HUT53860A (en) 1990-12-28
MY105067A (en) 1994-07-30
HU207993B (en) 1993-07-28
EP0363934B1 (en) 1993-12-29
CZ579789A3 (en) 1997-11-12
EP0562643A2 (en) 1993-09-29
DE68911834D1 (de) 1994-02-10
NO902598L (no) 1990-08-07
EP0562643A3 (en) 1994-05-18
FI98063C (fi) 1997-04-10
CA2000553A1 (en) 1990-04-13
SK579789A3 (en) 2000-08-14
YU48466B (sh) 1998-08-14
CA2000553C (en) 2001-12-04
EP0363934A1 (en) 1990-04-18
FI98063B (fi) 1996-12-31
NO902598D0 (no) 1990-06-12
HU896048D0 (en) 1990-11-28
IE893277L (en) 1990-04-13
IE940109L (en) 1990-04-13

Similar Documents

Publication Publication Date Title
IL91941A (en) Preparation of 6-Anoic and 7-Metanoic Fatty Acids and Their Substances and Intermediate Compounds and Acid 7-] 3-) 4-Fluorophenyl (-1-) 1- Methylethyl (a)
US5189164A (en) Processes for the synthesis of syn-(E)-3,5-dihydroxy-7-substituted hept-6-enoic and heptanoic acids and derivatives and intermediates thereof
KR960009434B1 (ko) 3-데메틸메발론산 유도체, 이의 제조방법 및 중간체
Arai et al. Asymmetric synthesis of α, β-epoxysulfones under phase-transfer catalyzed Darzens reaction
JP3233403B2 (ja) 光学活性な中間体および該製造法
WO1995011898A1 (en) Condensed pyridine type mevalonolactone intermediate and process for its production
WO1990003973A1 (en) Pyrimidinyl-substituted hydroxyacids, lactones and esters and pharmaceutical compositions containing them
JPH02188571A (ja) 化合物
EP0312269A2 (en) 3,5-Dihydroxy-6,8-nonadienoic acids and derivatives as hypocholesterolemic agents
AU693588B2 (en) Novel process for the preparation of diisopinocampheylchloroborane
Yusufoglu et al. Enantioselective synthesis and absolute configuration of both enantiomers of endo-brevicomin
JP3481325B2 (ja) 光学活性な３−オキシ−５−オキソ−６−ヘプテン酸誘導体の製法
JPH06256278A (ja) 光学活性α−カルバモイルアルカン酸誘導体およびその製法
RU2051907C1 (ru) Способ получения 7-замещенной гептен-6-овой кислоты
Uematsu et al. A Novel Class of Fungicides: Synthesis of (R)-and (S-) α-Benzylidene-γ-methyl-γ-butyrolactones
SI8911973A (sl) Postopek za pripravo 7-substituiranih-hept-6-enojskih in heptanojskih kislin ter njihovih derivatov in intermediatov
KR20070048741A (ko) 디아릴사이클로알킬 유도체의 제조방법
JP3006748B2 (ja) 光学活性な７−置換ピリジル−３，５−ジヒドロキシ−ヘプト−６−エン酸エステル誘導体の製法
JP2974181B2 (ja) シクロブタノールの新規な製造法
SA90100111B1 (ar) طريقة لتحضير 7- مستبدل- حمض هبت-6- ينويك وحمض هبتانويك ومشتقات منها
PT91980B (pt) Processo para a preparacao de acidos hept-6-enoicos e heptanoicos substituidos na posicao 7 e seus derivados e produtos intermediarios
JP2002114749A (ja) 光学活性２−ヒドロキシ−３−フェニルプロピオニトリル誘導体の製造法

Legal Events

Date Code Title Description
HC Change of name of proprietor(s)
KB Patent renewed
KB Patent renewed
KB Patent renewed
EXP Patent expired